By InvitationNot Applicable

A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures

United States100 participantsStarted 2024-03-25

Plain-language summary

The Sponsor is conducting a survey to understand how parents or legal guardians feel about the benefits of using the Precice IMLL System to lengthen limbs in children who are 12 years old or younger.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participants must be a parent or legal guardian of a subject already enrolled in the Precice IMLL arm of the study, "A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the Precice Intramedullary Limb Lengthening System (IMLL) in Pediatric Limb Lengthening Procedures" (NUVA.IMLL0723).
✓. The parent or legal guardian must be familiar with the patient's preoperative and postoperative condition, surgical treatment, postoperative care, and clinical outcomes.
✓. Informed consent from the parent or legal guardian of the patient is required for participation.

What they're measuring

Perceived clinical benefits of the Precice Intramedullary Limb Lengthening (IMLL) Survey System

Timeframe: 1 year post-op

Trial details

NCT IDNCT06741514

SponsorNuVasive

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-07-01

View on ClinicalTrials.gov More Limb Length Discrepancy trials